Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 44%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow is well-positioned for future growth and success, with strong second quarter outperformance and continued momentum in new account openings, record levels of ordering physicians, and margin expansion. The recent positive reimbursement implementation for its emerging plaque business, coupled with the company's core US FFRCT business delivering excellent performance, suggests a bright future ahead for HeartFlow. The company's strong financial outlook, with projected revenues of $305.8 million in 2026, indicates a high growth potential with potential for further margin expansion and upside to estimates driven by new account adds and incremental plaque analysis reimbursement. While there are potential risks in the form of competition, reimbursement changes, and financial risk, we believe the company's premium valuation is justified and recommend investing in HeartFlow's stock for long-term growth potential.

Bears say

HeartFlow is facing competitive risks as there are other AI-based platforms using CCTA data to diagnose CAD, which may lead to loss of market share. While the company has demonstrated strong business momentum, the TAM opportunity in the Plaque category might be overestimated, and relying solely on CT scanner manufacturers as partners poses a risk. Additionally, the evolving regulations around the use of AI in medical technology could impact the company's growth potential.

HeartFlow Inc (HTFL) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 44% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 9 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of Sep 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.